Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will explore the effects of exercise training on Long COVID patients to better understand the condition and how to treat it.
Who is the study for?
This trial is for adults over 18 who've had COVID-19 and are now experiencing Long COVID symptoms that have lasted more than a month. It's not for those with severe obesity, older than 65, or with exercise intolerance due to non-cardiorespiratory conditions, recent serious blood clots, heart inflammation from COVID, or pre-existing heart/lung diseases.Check my eligibility
What is being tested?
The study aims to see if exercise training can help people with Long COVID by improving their quality of life and physical function. Researchers will also look into how the condition affects heart and lung health as well as body's response to stress.See study design
What are the potential side effects?
Since the intervention involves exercise, potential side effects may include muscle soreness, fatigue, shortness of breath during activity (especially given the target population), and an increased risk of injury if not properly monitored.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Characterizing the impact of exercise training (cardiac rehabilitation) on HRqOL among patients with Long COVID
Characterizing the impact of exercise training (cardiac rehabilitation) on functional capacity among patients with Long COVID
Secondary outcome measures
Characterization of abnormalities contributing to Long COVID
Identify the mechanism by which exercise training improves functional capacity and HRqOL among patients with Long COVID
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: ExerciseExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
Find a Location
Who is running the clinical trial?
University of Colorado, DenverLead Sponsor
1,757 Previous Clinical Trials
2,166,109 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a blood clot in your leg or lung after having COVID-19.Your body mass index is higher than 35kg/m2.You are older than 65 years.You have trouble exercising because of something other than heart or lung problems, like arthritis or other bone or muscle issues.Adults over 18 years old with a confirmed history of COVID-19 and ongoing symptoms of Long COVID for more than 4 weeks.You have signs of heart problems related to COVID, like myocarditis.You still need extra oxygen after having COVID because of heart or lung problems caused by the infection.You have a history of heart or lung problems before getting sick.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger